Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Progression02:07

Tumor Progression

8.0K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
8.0K
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

4
Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
4
Lymphoid Cells and Tissues01:18

Lymphoid Cells and Tissues

4.0K
Lymphoid cells and tissues are integral to the immune system, which is crucial in maintaining our body's defense against harmful pathogens. They form the building blocks of lymphoid organs, which include the spleen, thymus, and lymph nodes.
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
4.0K
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

10.3K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
10.3K
Lineage Commitment01:21

Lineage Commitment

4.6K
Commitment is the  process whereby stem cells:
4.6K
Disorders of Leukocytes01:27

Disorders of Leukocytes

2.5K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
2.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Homeodynamic Rejuvenation: an adaptive framework for resetting skin aging.

Frontiers in aging·2026
Same author

Pro-aging effects of chronic glucocorticoid signaling.

Cell metabolism·2026
Same author

Exercise-induced changes in physical performance and circulating acyl-CoA binding protein/diazepam binding inhibitor (ACBP/DBI) in older adults with and without HIV.

The journals of gerontology. Series A, Biological sciences and medical sciences·2026
Same author

The long-lived immune system of centenarians.

Nature reviews. Immunology·2026
Same author

Exercise and the hallmarks of cardiovascular aging.

Ageing research reviews·2026
Same author

Correction: LPS responsiveness and neutrophil chemotaxis in vivo require PMN MMP-8 activity.

PloS one·2025

Related Experiment Video

Updated: Apr 18, 2026

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
09:02

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

22.8K

Molecular pathogenesis of CLL and its evolution.

David Rodríguez1, Gabriel Bretones, Javier R Arango

  • 1Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología-IUOPA, Universidad de Oviedo, 33006, Oviedo, Spain.

International Journal of Hematology
|January 30, 2015
PubMed
Summary

Next-generation sequencing reveals genetic complexity in chronic lymphocytic leukemia (CLL), uncovering new driver genes and intra-tumor heterogeneity. This advances understanding of CLL progression and offers new therapeutic targets.

More Related Videos

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
10:18

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

Published on: October 19, 2014

14.3K
VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma
15:07

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma

Published on: December 28, 2015

27.4K

Related Experiment Videos

Last Updated: Apr 18, 2026

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
09:02

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

22.8K
From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
10:18

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

Published on: October 19, 2014

14.3K
VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma
15:07

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma

Published on: December 28, 2015

27.4K

Area of Science:

  • Hematology
  • Oncology
  • Genetics

Background:

  • Chronic lymphocytic leukemia (CLL) is the most common adult leukemia in Western countries.
  • The molecular drivers of CLL development and progression are not fully understood.
  • Understanding CLL heterogeneity is crucial for improving patient outcomes.

Purpose of the Study:

  • To explore the molecular mechanisms underlying chronic lymphocytic leukemia (CLL).
  • To identify novel driver genes with prognostic and therapeutic implications in CLL.
  • To investigate the role of intra-tumor heterogeneity and epigenetic alterations in CLL.

Main Methods:

  • Application of next-generation sequencing (NGS) and deep sequencing techniques.
  • Analysis of the mutational landscape and genetic heterogeneity in CLL.
  • Investigation of aberrant DNA methylation patterns and clonal evolution.

Main Results:

  • NGS identified new, sometimes unexpected, driver genes in CLL with prognostic and therapeutic value.
  • CLL exhibits significant genetic and epigenetic heterogeneity, with low mutation recurrence.
  • Deep sequencing revealed substantial intra-tumor heterogeneity and clonal evolution, linked to poor outcomes.

Conclusions:

  • Massively parallel sequencing studies have provided significant insights into CLL complexity.
  • Identified driver genes and heterogeneity patterns can improve patient staging and clinical management.
  • Aberrant DNA methylation and intra-tumor heterogeneity represent potential therapeutic targets in CLL.